WFA Secretary-General Dongge Visits Japan's Sugiyama Obstetrics and Gynecology Hospital to Explore New Opportunities for China-Japan Reproductive Health Collaboration

On July 22, 2024, Dongge, Secretary-General of the World Fertility Industry Alliance (WFA), arrived in Tokyo, Japan, for a friendly visit to Sugiyama Obstetrics and Gynecology Hospital—the largest IVF hospital in Japan. During the visit, Secretary-General Dongge held in-depth discussions with the hospital’s director on WFA’s development, the current state of China’s IVF industry, and prospects for collaboration in reproductive health between China and Japan.

On July 22, 2024, Dongge, Secretary-General of the World Fertility Industry Alliance (WFA), arrived in Tokyo, Japan, for a friendly visit to Sugiyama Obstetrics and Gynecology Hospital—the largest IVF hospital in Japan. During the visit, Secretary-General Dongge held in-depth discussions with the hospital’s director on WFA’s development, the current state of China’s IVF industry, and prospects for collaboration in reproductive health between China and Japan.

During the meeting, Dongge provided a detailed introduction to WFA’s mission, vision, and its notable achievements in global reproductive health in recent years. He emphasized that the Alliance is committed to fostering communication and collaboration across the global reproductive healthcare industry, offering member institutions a broad platform for development and rich resource support. Secretary-General Dongge also outlined the current status of China’s IVF industry—including market scale, technological advancements, and the growing trend of Chinese patients seeking IVF services overseas.

From left to right: Director of Sugiyama Obstetrics and Gynecology Hospital, Japan; Dongge, Secretary-General of WFA; and Ding Xu, representative of Tianjin Jiahao Yun, a WFA member institution

The director of Sugiyama Obstetrics and Gynecology Hospital expressed strong interest and full agreement with Dongge’s presentation. He highly commended WFA’s pivotal role in the global reproductive health field and stated his strong willingness to join the Alliance as a valued member. The director noted that Sugiyama Obstetrics and Gynecology Hospital possesses advanced technologies and extensive clinical experience in IVF—particularly in oocyte nurturing and multiple ovarian stimulation protocols for advanced maternal age and women with severe ovarian insufficiency—where it has achieved remarkable outcomes. He expressed hope that membership in WFA would further enhance the hospital’s visibility in the Chinese market and enable it to deliver higher-quality medical services and cutting-edge reproductive technologies to Chinese patients.

During the meeting, both parties also conducted preliminary discussions on potential future collaborative initiatives, including technology exchange, professional training, and patient referral programs. They jointly affirmed that strengthened cooperation will further advance bilateral exchanges and collaboration in reproductive health between China and Japan—and contribute meaningfully to reproductive healthcare not only in both countries but globally.

Director of Sugiyama Obstetrics and Gynecology Hospital (left) and Dongge, Secretary-General of WFA

This visit not only deepened mutual understanding and friendship between China and Japan in the field of reproductive health but also opened up broad space and boundless possibilities for future collaboration and development. It is believed that, through joint efforts, China-Japan cooperation in reproductive health will yield even richer outcomes—injecting new vitality and momentum into reproductive healthcare in both nations and worldwide.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.